Revenue: The sum of all revenue fields included for a company's operating activities.
Sarepta Therapeutics, Inc. (SRPT) had Revenue of $1.90B for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$1.90B |
$235.24M |
|
$319.10M |
|
$1.58B |
|
$1.68B |
|
$218.08M |
|
$42.69M |
|
$260.77M |
|
$260.77M |
|
$235.24M |
|
$235.24M |
|
$235.24M |
|
$235.24M |
|
$218.08M |
|
$215.53M |
|
95.08M |
|
107.88M |
|
$2.47 |
|
$2.34 |
|
| Balance Sheet Financials | |
$3.07B |
|
$340.34M |
|
$889.71M |
|
$3.96B |
|
$731.68M |
|
$1.14B |
|
$1.70B |
|
$2.44B |
|
$1.53B |
|
$1.53B |
|
$1.53B |
|
96.90M |
|
| Cash Flow Statement Financials | |
$-205.79M |
|
$755.56M |
|
$124.81M |
|
$444.01M |
|
$1.12B |
|
$674.58M |
|
$184.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.20 |
|
-- |
|
-- |
|
0.43 |
|
0.74 |
|
83.22% |
|
11.47% |
|
11.47% |
|
11.33% |
|
13.71% |
|
12.37% |
|
$-342.74M |
|
-- |
|
-- |
|
-- |
|
0.48 |
|
0.43 |
|
3.16 |
|
115.52 |
|
15.40% |
|
15.40% |
|
5.94% |
|
8.83% |
|
$15.77 |
|
$-3.18 |
|
$-1.91 |
|